Does MOLNUPIRAVIR Cause Product use issue? 706 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 706 reports of Product use issue have been filed in association with MOLNUPIRAVIR (LAGEVRIO). This represents 14.8% of all adverse event reports for MOLNUPIRAVIR.
706
Reports of Product use issue with MOLNUPIRAVIR
14.8%
of all MOLNUPIRAVIR reports
21
Deaths
41
Hospitalizations
How Dangerous Is Product use issue From MOLNUPIRAVIR?
Of the 706 reports, 21 (3.0%) resulted in death, 41 (5.8%) required hospitalization, and 3 (0.4%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOLNUPIRAVIR. However, 706 reports have been filed with the FAERS database.
What Other Side Effects Does MOLNUPIRAVIR Cause?
No adverse event (614)
Covid-19 (396)
Wrong technique in product usage process (380)
Product use in unapproved indication (296)
Diarrhoea (259)
Accidental underdose (207)
Product use complaint (206)
Rash (200)
Underdose (183)
Nausea (180)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which MOLNUPIRAVIR Alternatives Have Lower Product use issue Risk?
MOLNUPIRAVIR vs MOLSIDOMINE
MOLNUPIRAVIR vs MOMELOTINIB
MOLNUPIRAVIR vs MOMETASONE
MOLNUPIRAVIR vs MOMETASONE FUROATE
MOLNUPIRAVIR vs MOMETASONE FUROATE\OLOPATADINE